Ascendis Pharma A/S

NASDAQ (USD): Ascendis Pharma A/S (ASND)

Last Price

131.57

Today's Change

-2.47 (1.84%)

Day's Change

131.05 - 137.54

Trading Volume

391,656

Overview

Market Cap

7 Billion

Shares Outstanding

59 Million

Avg Volume

417,762

Avg Price (50 Days)

131.75

Avg Price (200 Days)

134.41

PE Ratio

-17.22

EPS

-7.64

Earnings Announcement

05-Feb-2025

Previous Close

134.04

Open

135.30

Day's Range

131.0501 - 137.54

Year Range

111.09 - 161.0

Trading Volume

391,656

Price Change Highlight

1 Day Change

-1.84%

5 Day Change

-0.85%

1 Month Change

1.31%

3 Month Change

3.35%

6 Month Change

-3.99%

Ytd Change

-4.66%

1 Year Change

-1.45%

3 Year Change

11.96%

5 Year Change

-5.48%

10 Year Change

598.73%

Max Change

598.73%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment